The economic burden of gastrointestinal stromal tumor (GIST) recurrence in patients who have received adjuvant imatinib therapy

J Med Econ. 2015 Mar;18(3):241-8

View abstract

Authors

Guerin A, Sasane M, Gauthier G, Keir CH, Zhdavana M, Wu EQ